Saudi Arabia Clinical Trial Supplies Market Size & Outlook

The clinical trial supplies market in Saudi Arabia is expected to reach a projected revenue of US$ 9.9 million by 2030. A compound annual growth rate of 5.1% is expected of Saudi Arabia clinical trial supplies market from 2024 to 2030.
Revenue, 2023 (US$M)
$7.0
Forecast, 2030 (US$M)
$9.9
CAGR, 2024 - 2030
5.1%
Report Coverage
Saudi Arabia

Saudi Arabia clinical trial supplies market, 2018-2030 (US$M)

Saudi

Saudi Arabia clinical trial supplies market highlights

  • The Saudi Arabia clinical trial supplies market generated a revenue of USD 7.0 million in 2023 and is expected to reach USD 9.9 million by 2030.
  • The Saudi Arabia market is expected to grow at a CAGR of 5.1% from 2024 to 2030.
  • In terms of segment, phase iii was the largest revenue generating phase in 2023.
  • Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.


Clinical trial supplies market data book summary

Market revenue in 2023USD 7.0 million
Market revenue in 2030USD 9.9 million
Growth rate5.1% (CAGR from 2023 to 2030)
Largest segmentPhase iii
Fastest growing segmentPhase I
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPhase I, Phase II, Phase III
Key market players worldwideAlmac Group, Catalent Inc, Waldencast PLC Class A, PCI Technology, Sharp Corp, Thermo Fisher Scientific Inc, PAREXEL, Marken, KLIFO, BioCair


Other key industry trends

  • In terms of revenue, Saudi Arabia accounted for 0.3% of the global clinical trial supplies market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, South Africa clinical trial supplies market is projected to lead the regional market in terms of revenue in 2030.
  • Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 9.9 million by 2030.

Phase iii was the largest segment with a revenue share of 54.29% in 2023. Horizon Databook has segmented the Saudi Arabia clinical trial supplies market based on phase i, phase ii, phase iii covering the revenue growth of each sub-segment from 2018 to 2030.


Availability of low-cost clinical resources, presence of qualified investigators, and ease in patient recruitment are some of the major factors boosting the growth of clinical trial supplies market in this country.

Advancements in technology, rise in disease prevalence, and quicker regulatory approval as compared to countries such as China, India, and Brazil are expected to further fuel growth of clinical trial supplies market in the region.

Presence of key players such as PAREXEL International Corporation and increase in the number of clinical trials are among factors further expected to boost competition and expand the market for clinical trial supplies.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Clinical Trial Supplies Market Companies

Name Profile # Employees HQ Website

Saudi Arabia clinical trial supplies market size, by phase, 2018-2030 (US$M)

Saudi Arabia Clinical Trial Supplies Market Outlook Share, 2023 & 2030 (US$M)

Saudi Arabia clinical trial supplies market size, by phase, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more